Also known as آسٹیوپوروسس مینجمنٹ
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology), MACG (USA), UEG GI ASSOCIATE (VIENNA), MMED Gastroenterology Fellow (UK)
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology), MACG (USA), UEG GI ASSOCIATE (VIENNA), MMED Gastroenterology Fellow (UK)
Internal Medicine Specialist
B.Sc, M.B.B.S., Certification in Diabetes , F.C.P.S (Medicine), MACP (USA), Fellow of Gastroenterology, MRCP 1 & 2 UK, MACG(USA)
Internal Medicine Specialist
B.Sc, M.B.B.S., Certification in Diabetes , F.C.P.S (Medicine), MACP (USA), Fellow of Gastroenterology, MRCP 1 & 2 UK, MACG(USA)
Cardiologist
M.B.B.S, F.C.P.S
General Physician
MBBS, MRCGP [INT]
Internal Medicine Specialist
M.B.B.S, F.C.P.S
Internal Medicine Specialist
M.B.B.S., M.D (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Gastroenterologist
M.B.B.S., F.C.P.S. (Gastroenterology)
Gastroenterologist
M.B.B.S, Doctor of Medicine (Gastroenterology), M.C.P.S (Medicine), D.P.H (Endocrinology)
Gastroenterologist
M.B.B.S, Doctor of Medicine (Gastroenterology), M.C.P.S (Medicine), D.P.H (Endocrinology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures